DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma

Overview of attention for article published in PLOS ONE, April 2012

Altmetric Badge

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 52 Mendeley
citeulike: 1 CiteULike

Summary Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Repurposing gemcitabine for glioblastoma treatment: The role of drug-conjugates and nanoparticles as drug delivery systems

Article in Journal of Drug Delivery Science and Technology (June 2024)

Leveraging the replication‐competent avian‐like sarcoma virus/tumor virus receptor‐A system for modeling human gliomas

Article in Glia (February 2021)

TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma

Article in Neuro-Oncology (February 2019)